SCHEMBL1018314

SCHEMBL1018314

CCC1CCCC2CN(C(=O)CN3CCc4cc(-n5ccc(C(F)(F)F)n5)ccc4C3)CCN12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.34
MGLL Q99685 1/20 0.34
ALDH1A1 P00352 3/20 0.32
GAA P10253 2/20 0.32
PKM P14618 2/20 0.32
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
HSD17B10 Q99714 1/20 0.32
KDM4E B2RXH2 2/20 0.32
S1PR1 P21453 1/20 0.31
RORC P51449 1/20 0.31
EGFR P00533 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
GRM2 Q14416 1/20 0.31
TSHR P16473 1/20 0.31
FLT3 P36888 2/20 0.30
CHEK1 O14757 1/20 0.30
CCR1 P32246 1/20 0.30
IRAK4 Q9NWZ3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12707107 1.00 POLB (0.34) POLBMGLLALDH1A1GAAPKM
SCHEMBL12707095 0.92 GAA (0.35) POLBMGLLALDH1A1GAAPKM
SCHEMBL1016803 0.92 GAA (0.35) POLBMGLLALDH1A1GAAPKM
SCHEMBL1016845 0.85 POLB (0.39) POLBALDH1A1GAANPC1KDM4E
SCHEMBL1603598 0.85 TMEM97 (0.39) POLBMGLLALDH1A1GAAPKM
SCHEMBL1020433 0.85 KMT2A (0.42) ALDH1A1GAAPKMMAPTHSD17B10
SCHEMBL12707120 0.85 KMT2A (0.42) ALDH1A1GAAPKMMAPTHSD17B10
SCHEMBL12707109 0.80 CARM1 (0.41) ALDH1A1GAAPKMHSD17B10KDM4E
SCHEMBL1604154 0.80 CARM1 (0.41) ALDH1A1GAAPKMHSD17B10KDM4E
SCHEMBL1018774 0.79 KDM2B (0.38) ALDH1A1GAAPKMNPC1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
EP-1998620-B1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES NEUROGEN CORP (US) 2011-01-12 EP disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues HRH3, HRH4, HRH1 POLB 3403/4885MGLL 2755/4885ALDH1A1 1229/4885
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 POLB 3403/4885MGLL 2755/4885ALDH1A1 1229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.